Thursday October 18, 2018

Alzheimer’s disease linked to several unsaturated fatty acids in the brain: Study

0
//
98
Cognitive Impairment
Alzheimer's disease patient Isidora Tomaz, 82, sits in an armchair in her house in Lisbon, Portugal. It’s predicted that by 2050, 135 million Americans are going to suffer from mild cognitive impairment, a precursor of Alzheimer's. VOA
Republish
Reprint

London, March 23, 2017: Researchers have found that several unsaturated fatty acids in the brain may be associated with the progression of Alzheimer’s disease.

Alzheimer’s disease is a neurodegenerative disorder, which causes impaired memory, executive function and language. It accounts for 60-80 per cent of total dementia cases worldwide, with over 46 million people suffering from the disease worldwide. The number of patients is estimated to rise to 131.5 million by 2050.

Currently, it is thought that the main reason for developing memory problems in dementia is the presence of two big molecules in the brain called tau and amyloid proteins — that are shown to start accumulating in the brain up to 20 years prior to the onset of the disease.

NewsGram brings to you current foreign news from all over the world.

However, the findings, published in the journal PLOS Medicine, showed that the metabolism of omega-3 and omega-6 unsaturated fatty acids were significantly decreased in Alzheimer’s brains when compared to brains from healthy patients.

“Our results show a potentially crucial and unexpected role for fats in the onset of dementia. Most surprisingly, we found that a supposedly beneficial omega-3, DHA, actually increased with the progression of the disease,” said Cristina Legido Quigley from King’s College London.

In the study, the team looked at brain tissue samples from 43 people ranging in age from 57 to 95 years old.

The researchers then measured the metabolite levels of the brain regions that are commonly associated with neurodegerative diseases — the middle frontal gyrus and the inferior temporal gyrus — as well as the metabolite levels in a brain area that is not normally affected by the disease’s pathology — the cerebellum.

Check out NewsGram for latest international news updates.

The results showed that unsaturated fatty acid metabolism is significantly dysregulated in the brains of patients with varying degrees of Alzheimer pathology.

The main molecules that were different were six small fats — docosahexaenoic acid, linoleic acid, arachidonic acid, linolenic acid, eicosapentaenoic acid, and oleic acid — including omegas, which changed in abundance in different regions of the brain. (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Novel AI Tool May help to Predict Alzheimer’s risk

Globally, around 50 million people have dementia and the total number is projected to reach 82 million in 2030 and 152 in 2050, according to the World Health Organization

0
alzheimer's
New AI tool can predict Alzheimer's risk. Pixabay

A team of scientists, including one of an Indian-origin, has successfully trained a new Artificial Intelligence (AI) algorithm that may soon help doctors to make accurate predictions regarding cognitive decline leading to Alzheimer’s disease and provide intervention.

The team, from the McGill University in Canada, designed an algorithm that learns signatures from magnetic resonance imaging (MRI), genetics, and clinical data.

This specific algorithm can help predict whether an individual’s cognitive faculties are likely to deteriorate towards Alzheimer’s in the next five years.

“At the moment, there are limited ways to treat Alzheimer’s and the best evidence we have is for prevention. Our AI methodology could have significant implications as a ‘doctor’s assistant’ that would help stream people onto the right pathway for treatment,” Mallar Chakravarty, assistant professor at the University’s Department of Psychiatry.

“For example, one could even initiate lifestyle changes that may delay the beginning stages of Alzheimer’s or even prevent it altogether,” she added.

Alzheimer's
In Alzheimer’s disease, patients start losing memory, Pixabay

For the study, published in the journal PLOS Computational Biology, the team trained their algorithms using data from more than 800 people ranging from normal healthy seniors to those experiencing mild cognitive impairment, and Alzheimer’s disease patients.

“We are currently working on testing the accuracy of predictions using new data. It will help us to refine predictions and determine if we can predict even farther into the future,” Chakravarty noted.

With more data, doctors would be able to better identify those in the population at greatest risk for cognitive decline leading to Alzheimer’s.

You May Also Like to Read About- Epileptic Pregnant Women Often Have Higher Risk of Death

Globally, around 50 million people have dementia and the total number is projected to reach 82 million in 2030 and 152 in 2050, according to the World Health Organization.

Alzheimer’s disease, the most common form of dementia, may contribute to 60-70% of cases. Presently, there is no truly effective treatment for this disease. (IANS)